blog

Join the ZERO Cancer Movement

Support Awareness, Research & Advocacy At 4Kscore, our team is investing in the health and well-being of men facing a prostate cancer diagnosis. As part of our fall event schedule, we’re joining OPKO Health and thousands of prostate cancer patients, survivors, families and physicians participating in the ZERO Prostate Cancer Run/Walk movement.   About the […]

blog

2018 AUA Exhibition:

OPKO Health Focuses Attention on 4Kscore Test Urologists from across the U.S. and over 100 countries around the globe gathered last month in San Francisco for the 113th American Urological Association (AUA) Conference. With this year’s event attendance topping 16,000, the annual event remains the largest urology meeting in the world. OPKO Health, developers of […]

Press Release

OPKO Health’s 4Kscore® Test Highlighted in Podium Presentation at 112th American Urological Association Annual Meeting

Prospective study conducted at Veteran Affairs hospitals confirms 4Kscore accurately predicts aggressive prostate cancer MIAMI, May 18, 2017 (GLOBE NEWSWIRE) — OPKO Health, Inc. (NASDAQ:OPK), announces that data from a prospective study conducted at Veteran Affairs (VA) hospitals confirming the 4Kscore test’s ability to accurately predict aggressive prostate cancer were presented in a podium presentation […]

Press Release

OPKO Announces Multiple Presentations at the 112th AUA Annual Meeting

Highlights 4Kscore’s ability to predict aggressive prostate cancer Showcasing 4Kscore and Claros 1 Point-of-Care System at Exhibit Booth #904 MIAMI, May 15, 2017 (GLOBE NEWSWIRE) — OPKO Health, Inc. (Nasdaq:OPK) announces that multiple podium and poster presentations highlighting the Company’s 4Kscore test will be presented at the 112th American Urological Association (AUA) Annual Meeting taking […]

blog

Celebrate National Prostate Cancer Awareness Month!

September is National Prostate Cancer Awareness Month, an annual observation to shed light on the importance of prostate health and the risk factors associated with prostate cancer. The Prevalence of Prostate Cancer: What You Should Know According to the Prostate Cancer Foundation, prostate cancer is one of the most common cancers in men behind skin […]

Press Release

Study Demonstrates OPKO’s 4Kscore Test Reduces Unnecessary Prostate Biopsies While Improving Risk Prediction for Aggressive Prostate Cancer

OPKO Health, Inc. (NYSE: OPK) announced today the results of a study for the 4Kscore® Test’s clinical utility in reducing the number of prostate biopsies performed, while increasing the probability of detecting aggressive prostate cancer in men with abnormal prostate-specific antigen (PSA) levels and or digital rectal examination (DRE) results. The peer-reviewed study, “The 4Kscore® Test […]

News

OPKO’s 4Kscore Prostate Biopsy Alternative Might Reduce Unnecessary Biopsies

ORLANDO—The 4Kscore, an algorithmic analysis of data from a blood test that combines four kallikrein assays with clinical information to identify the probability of high-grade prostate tumors, could dramatically reduce the number of unnecessary prostate biopsies, according to a multi-institutional prospective study (Abstract 1) presented during the 2015 Genitourinary Cancers Symposium.1 “The 4Kscore demonstrated excellent […]

News

OPKO Health CEO Dr. Frost Discusses BioReference Labs Acquisition, Impact of 4Kscore Test with Jim Cramer on Mad Money

OPKO Health CEO Dr. Phillip Frost visited Jim Cramer on Mad Money September 25, 2015, to explain the recent acquisition of Bio-Reference Laboratories and the impact it expects to have on our overall business. As Dr. Frost explained: “This is probably the best, and most interesting acquisition I have ever made.  First of all we realized […]